digital health tools glp-1 weight management Optimizing Therapy Through Remote Monitoring: A Protocol for Enhanced Safety and Efficacy Do the new weight-loss drugs

Unlock the full potential of your weight loss medication with GLP-1 weight loss nutrition coaching

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.

Studies show that 70-80% of people regain lost weight within one year of stopping Ozempic, as appetite hormones return to baseline levels

Experts explain why hunger, food noise and other health changes return after stopping weight loss drugs and how to hold onto your progress.

Results Overall, 16 injectable semaglutide, 8 oral semaglutide, and 2 injectable liraglutide follow-on products were analyzed alongside originator products